Tags

Type your tag names separated by a space and hit enter

The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample.
Drug Alcohol Depend 2015; 148:40-6DA

Abstract

BACKGROUND

The purpose of this study was to assess the procedural validity of the substance disorder modules of the lay-administered Alcohol Use Disorder and Associated Disabilities Interview Schedule, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Version (AUDADIS-5) through clinician re-appraisal re-interviews.

METHODS

The study employed a test-retest design among 712 respondents from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). A clinician-administered, semi-structured interview, the Psychiatric Research Interview for Substance and Mental Disorders, DSM-5 version (PRISM-5) was used as the re-appraisal. Kappa coeffients indicated concordance of the AUDADIS-5 and PRISM-5 for DSM-5 substance use disorder diagnoses, while intraclass correlation coefficients (ICC) indicated concordance on dimensional scales indicating the DSM-5 criteria count for each disorder.

RESULTS

With few exceptions, concordance of the AUDADIS-5 and the PRISM-5 for DSM-5 diagnoses of substance use disorders ranged from fair to good (κ=0.40-0.72). Concordance on dimensional scales was excellent (ICC≥0.75) for the majority of DSM-5 SUD diagnoses, and fair to good (ICC=0.43-0.72) for most of the rest.

CONCLUSIONS

As indicated by concordance with a semi-structured clinician-administered re-appraisal, the procedural validity of the AUDADIS-5 DSM-5 substance use disorder diagnoses found in this study indicates that these AUDADIS-5 diagnoses are useful tools in epidemiologic studies. The considerably stronger concordance of the AUDADIS-5 and PRISM-5 dimensional DSM-5 SUD measures supports a current movement to place more emphasis on dimensional measures of psychopathology, and suggests that such measures may be more informative than binary diagnoses for research, and possibly for clinical purposes as well.

Authors+Show Affiliations

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA; New York State Psychiatric Institute, New York, NY 10032, USA. Electronic address: deborah.hasin@gmail.com.New York State Psychiatric Institute, New York, NY 10032, USA.New York State Psychiatric Institute, New York, NY 10032, USA.New York State Psychiatric Institute, New York, NY 10032, USA.Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA; New York State Psychiatric Institute, New York, NY 10032, USA.Laboratory of Epidemiology and Biometry, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.Laboratory of Epidemiology and Biometry, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA; New York State Psychiatric Institute, New York, NY 10032, USA.Laboratory of Epidemiology and Biometry, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.Laboratory of Epidemiology and Biometry, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.Laboratory of Epidemiology and Biometry, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 20892, USA.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Validation Studies

Language

eng

PubMed ID

25604321

Citation

Hasin, Deborah S., et al. "The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): Procedural Validity of Substance Use Disorders Modules Through Clinical Re-appraisal in a General Population Sample." Drug and Alcohol Dependence, vol. 148, 2015, pp. 40-6.
Hasin DS, Greenstein E, Aivadyan C, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alcohol Depend. 2015;148:40-6.
Hasin, D. S., Greenstein, E., Aivadyan, C., Stohl, M., Aharonovich, E., Saha, T., ... Grant, B. F. (2015). The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug and Alcohol Dependence, 148, pp. 40-6. doi:10.1016/j.drugalcdep.2014.12.011.
Hasin DS, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): Procedural Validity of Substance Use Disorders Modules Through Clinical Re-appraisal in a General Population Sample. Drug Alcohol Depend. 2015 Mar 1;148:40-6. PubMed PMID: 25604321.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. AU - Hasin,Deborah S, AU - Greenstein,Eliana, AU - Aivadyan,Christina, AU - Stohl,Malki, AU - Aharonovich,Efrat, AU - Saha,Tulshi, AU - Goldstein,Rise, AU - Nunes,Edward V, AU - Jung,Jeesun, AU - Zhang,Haitao, AU - Grant,Bridget F, Y1 - 2014/12/18/ PY - 2014/09/18/received PY - 2014/11/25/revised PY - 2014/12/07/accepted PY - 2015/1/22/entrez PY - 2015/1/22/pubmed PY - 2015/12/31/medline KW - Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 KW - Alcohol use disorder KW - Psychiatric Research Interview for Substance and Mental Disorders-5 KW - Reliability KW - Substance use disorder KW - Validity SP - 40 EP - 6 JF - Drug and alcohol dependence JO - Drug Alcohol Depend VL - 148 N2 - BACKGROUND: The purpose of this study was to assess the procedural validity of the substance disorder modules of the lay-administered Alcohol Use Disorder and Associated Disabilities Interview Schedule, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Version (AUDADIS-5) through clinician re-appraisal re-interviews. METHODS: The study employed a test-retest design among 712 respondents from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). A clinician-administered, semi-structured interview, the Psychiatric Research Interview for Substance and Mental Disorders, DSM-5 version (PRISM-5) was used as the re-appraisal. Kappa coeffients indicated concordance of the AUDADIS-5 and PRISM-5 for DSM-5 substance use disorder diagnoses, while intraclass correlation coefficients (ICC) indicated concordance on dimensional scales indicating the DSM-5 criteria count for each disorder. RESULTS: With few exceptions, concordance of the AUDADIS-5 and the PRISM-5 for DSM-5 diagnoses of substance use disorders ranged from fair to good (κ=0.40-0.72). Concordance on dimensional scales was excellent (ICC≥0.75) for the majority of DSM-5 SUD diagnoses, and fair to good (ICC=0.43-0.72) for most of the rest. CONCLUSIONS: As indicated by concordance with a semi-structured clinician-administered re-appraisal, the procedural validity of the AUDADIS-5 DSM-5 substance use disorder diagnoses found in this study indicates that these AUDADIS-5 diagnoses are useful tools in epidemiologic studies. The considerably stronger concordance of the AUDADIS-5 and PRISM-5 dimensional DSM-5 SUD measures supports a current movement to place more emphasis on dimensional measures of psychopathology, and suggests that such measures may be more informative than binary diagnoses for research, and possibly for clinical purposes as well. SN - 1879-0046 UR - https://www.unboundmedicine.com/medline/citation/25604321/The_Alcohol_Use_Disorder_and_Associated_Disabilities_Interview_Schedule_5__AUDADIS_5_:_procedural_validity_of_substance_use_disorders_modules_through_clinical_re_appraisal_in_a_general_population_sample_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0376-8716(14)01990-5 DB - PRIME DP - Unbound Medicine ER -